Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions.

Watad, A; Amital, H; Shoenfeld, Y

Watad, A; Amital, H; Shoenfeld, Y.

Affiliation

Watad A; 1 Department of Medicine 'B', Sheba Medical Center, Israel.
Amital H; 2 Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Israel.
Shoenfeld Y; 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Lupus ; 26(10): 1015-1022, 2017 Sep.

Article in En | MEDLINE | ID: mdl-28420062

Subject(s)

Autoimmune Diseases/drug therapy; Immunoglobulins, Intravenous/therapeutic use; Immunologic Factors/therapeutic use; Drug Costs; Glucocorticoids/adverse effects; Glucocorticoids/therapeutic use; Humans; Immunoglobulins, Intravenous/adverse effects; Immunoglobulins, Intravenous/economics; Immunologic Factors/adverse effects; Immunologic Factors/economics

Key words

IVIg; biological agents; corticosteroids; immunosuppression; intravenous immunoglobulin; steroid-sparing effect

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Immunoglobulins, Intravenous / Immunologic Factors Limits: Humans Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2017 Type: Article Affiliation country: Israel

Fulltext

XML

PubMed Links

Search on Google